This is early beta for now! Can't handle all templates properly
Hankkija
| Vastaanotettu Hilmaan | 2019-12-31 |
| Ilmoituksen numero | 2019-022832 |
| TED numero | 2019/S 214-526172 |
| Ostajaorganisaatio | National Institute for Health and Welfare (2229500-6 ) PL 30 FI-00271 Helsinki https://thl.fi/en/web/thlfi-en |
| Hankinnan otsikkotiedot | Next-generation Sequencing Services 2018-2020 (2021, 2022) |
| Hankinnan yhteenlaskettu kokonaisarvo koko ajalle (ilman alv:ta) arvio | |
| Hankinnan yhteenlaskettu kokonaisarvo koko ajalle (ilman alv:ta) lopullinen | 540 000 EUR |
| Alkuperäinen ilmoitus | https://www.hankintailmoitukset.fi/en/public/procurement/24616/notice/29720/overview |
| Originaali JSON tietue | 29720.json |
Ostettava
| Hankinnan lyhyt kuvaus | THL has prepared or will prepare DNA and RNA extracts of samples from natural and man-made environments and humans for microbiological characterization. The microbiome targets include primarily bacteria (16S rRNA) and fungi (ITS sequence), but may also include eg. archaea and protozoa (18S rRNA). The exact total number of samples or the total number of batches per each amplicon target (bacteria, fungi, others) is not known. All batches will contain at least one negative and one positive control (mock community) sample. In total, we are anticipating to request bacterial and fungal amplicon sequencing service of several batches between 100 and 500 samples within the first 12 months, and similar throughput for following years. |
| Hankintanimikkeistö (CPV) pää | |
| Hankintanimikkeistö (CPV) muut | Research laboratory services (73111000) |
| Aluekoodi | FI, FIZ |
| Pääasiallinen suorituspaikka |
Sopimukset
| Päätös päivämäärä | 2019-01-21 |
| Sopimusnumero | |
| Myyjät | Macrogen Inc. (NL) |
Ostettava
| Hankinnan lyhyt kuvaus | Bacterial DNA extraction and whole genome sequencing service (complete service from nucleic acids or from a bacterial strain) THL will purchase both bacterial DNA extraction and whole genome sequencing service or just the latter depending on our needs. Bacterial cultures or bacterial DNA extracts of bacterial isolates from clinical human cases will be produced by the customer. The bacterial cultures sent for DNA extraction belong to biosafety level 2 or 2+ (BSL-2 or BSL-2+), e.g. Streptococcus pneumoniae. The bacterial cultures will be inactivated before shipping. THL uses Illumina sequencing technology in house and the sequence data produced by the service provider must be comparable with the sequence data obtained in THL. The requirements for the data produced by the service provider are specified in the minimum requirements section. The sequence data will be used for microbiological strain typing and characterization. |
| Hankintanimikkeistö (CPV) pää | |
| Hankintanimikkeistö (CPV) muut | Research laboratory services (73111000) |
| Aluekoodi | FI, FIZ |
| Pääasiallinen suorituspaikka |
Sopimukset
| Päätös päivämäärä | 2019-01-21 |
| Sopimusnumero | |
| Myyjät | Macrogen Inc. (NL) |
